Molecular introduction to head and neck cancer (HNSCC) carcinogenesis

British Journal of Plastic Surgery
David ChinWilliam B Coman

Abstract

Of all human cancers, HNSCC is the most distressing affecting pain, disfigurement, speech and the basic survival functions of breathing and swallowing. Mortality rates have not significantly changed in the last 40 years despite advances in radiotherapy and surgical treatment. Molecular markers are currently being identified that can determine prognosis preoperatively by routine tumour biopsy leading to improved management of HNSCC patients. The approach could help decide which early stage patient should have adjuvant neck dissection and radiotherapy, and whether later stage patients with operable lesions would benefit from resection and reconstructive surgery or adopt a conservative approach to patients with poor prognosis regardless of treatment. In the future, understanding these basic genetic changes in HNSCC would be important for the management of HNSCC.

References

Oct 1, 1992·European Journal of Cancer. Part B, Oral Oncology·D SaranathM G Deo
Jul 5, 1991·Science·M HollsteinC C Harris
Jun 6, 1991·Nature·A J LevineC A Finlay
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Dec 1, 1990·Archives of Otolaryngology--head & Neck Surgery·W D MerrittT M Gilmer
May 1, 1989·Japanese Journal of Cancer Research : Gann·D SaranathM G Deo
May 16, 1985·Nature·G Klein, E Klein
Jan 1, 1987·Annual Review of Genetics·F G HaluskaC M Croce
Jul 15, 1983·Science·J J Yunis
Jan 1, 1983·Annual Review of Biochemistry·J M Bishop
Jul 1, 1995·Archives of Otolaryngology--head & Neck Surgery·S D MeredithM E Williams
Feb 16, 1995·The New England Journal of Medicine·J A BrennanD Sidransky
Feb 1, 1995·Archives of Otolaryngology--head & Neck Surgery·M P CopperG B Snow
Jan 1, 1995·The Journal of Laryngology and Otology·J S RubinP Etkind
Nov 1, 1993·Archives of Otolaryngology--head & Neck Surgery·M E WilliamsP A Levine
Dec 16, 1993·Nature·Y XiongD Beach
Jan 1, 1993·Annual Review of Biochemistry·A J Levine
Oct 1, 1993·Archives of Otolaryngology--head & Neck Surgery·J K FieldJ L Gluckman
Jan 1, 1993·Virchows Archiv. A, Pathological Anatomy and Histopathology·M Yamamoto, H Takahashi
Dec 11, 1995·International Journal of Cancer. Journal International Du Cancer·W D FoulkesE L Franco
Jan 1, 1997·Trends in Genetics : TIG·A HartmannS S Sommer
Apr 17, 1997·Oncogene·V PapadimitrakopoulouL Mao
Jul 25, 1997·The Journal of Biological Chemistry·K G ColemanK R Webster
Jan 8, 1998·International Journal of Cancer. Journal International Du Cancer·R KyomotoM Fukumoto
Aug 12, 1998·The Journal of Surgical Research·J M RoeslerM B Wang
May 27, 1999·Seminars in Cancer Biology·T Veikkola, K Alitalo
Jul 9, 1999·The Journal of Pathology·M G van OijenP J Slootweg
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Apr 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·J R GrandisJ D Kim
Oct 4, 2000·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·K NylanderP A Hall
Jun 19, 2001·International Journal of Cancer. Journal International Du Cancer·V M van HoutenR H Brakenhoff

❮ Previous
Next ❯

Citations

Sep 1, 2005·Annals of Surgical Oncology·Harriet S PatmoreJohn Greenman
Mar 29, 2014·International Journal of Otolaryngology·Owen Pyeko MenachHerbert Ouma Oburra
Dec 24, 2009·Head & Neck·Marija Pastorcic-GrgicMarko Grgic
May 15, 2012·Biochimica Et Biophysica Acta·Giuseppe PalmaClaudio Arra
Mar 17, 2006·Cytokine & Growth Factor Reviews·Ralph Pries, Barbara Wollenberg
Mar 29, 2016·World Journal of Methodology·Kiran Dahiya, Rakesh Dhankhar
Jan 1, 2012·Clinical Medicine Insights. Ear, Nose and Throat·Pyeko MenachAsmeeta Patel
Jul 13, 2006·Expert Review of Anticancer Therapy·David ChinWilliam B Coman
Oct 6, 2006·Expert Review of Anticancer Therapy·Ralph PriesBarbara Wollenberg
Jul 3, 2018·Oncotarget·Lisa SchulzBarbara Wollenberg
Oct 7, 2018·Clinical Oral Investigations·Nashwan Al-AfifiAnand Ramanathan
Feb 20, 2018·Oncology Letters·Karl-Ludwig BruchhageRalph Pries
Oct 12, 2019·Chinese Medical Sciences Journal = Chung-kuo I Hsüeh K'o Hsüeh Tsa Chih·Zheng-Zheng LiuYong-Quan Tian
Sep 5, 2006·Archives of Pathology & Laboratory Medicine·Sigrid Wayne, Robert A Robinson
Jul 3, 2021·Biomolecules·Jacek KabzinskiIreneusz Majsterek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis